Erturk, K. Et Al. 2016. Serum activated leukocyte cell adhesion molecule and intercellular adhesion molecule-1 in patients with gastric cancer: Can they be used as biomarkers?. BIOMEDICINE & PHARMACOTHERAPY , vol.77 , 86-91.

Erturk, K., Tastekin, D., Bilgin, E., Serilmez, M., Bozbey, H. U., & Sakar, B., (2016). Serum activated leukocyte cell adhesion molecule and intercellular adhesion molecule-1 in patients with gastric cancer: Can they be used as biomarkers?. BIOMEDICINE & PHARMACOTHERAPY , vol.77, 86-91.

Erturk, Kayhan Et Al. "Serum activated leukocyte cell adhesion molecule and intercellular adhesion molecule-1 in patients with gastric cancer: Can they be used as biomarkers?," BIOMEDICINE & PHARMACOTHERAPY , vol.77, 86-91, 2016

Erturk, Kayhan Et Al. "Serum activated leukocyte cell adhesion molecule and intercellular adhesion molecule-1 in patients with gastric cancer: Can they be used as biomarkers?." BIOMEDICINE & PHARMACOTHERAPY , vol.77, pp.86-91, 2016

Erturk, K. Et Al. (2016) . "Serum activated leukocyte cell adhesion molecule and intercellular adhesion molecule-1 in patients with gastric cancer: Can they be used as biomarkers?." BIOMEDICINE & PHARMACOTHERAPY , vol.77, pp.86-91.

@article{article, author={Kayhan ERTÜRK Et Al. }, title={Serum activated leukocyte cell adhesion molecule and intercellular adhesion molecule-1 in patients with gastric cancer: Can they be used as biomarkers?}, journal={BIOMEDICINE & PHARMACOTHERAPY}, year=2016, pages={86-91} }